Skip to main content

Table 1 The main demographic and clinical characteristics of the four study groups

From: Epigenetic features of FoxP3 in children with cow’s milk allergy

  Subjects with CMA at diagnosis Subjects outgrown CMA Healthy subjects
EHCF + LGG Other formulas
Group 1 Group 2 Group 3 Group 4
Number 10 10 10 10
Male, number (%) 7 (70) 7 (70) 6 (60) 4 (40)
Age, months (SD) 5.5 (0.7) 16.9 (0.9) 17 (0.9) 9 (4)
Body weight, kg (SD) 7.385 (964.7) 12.047 (682.4) 12.273 (776.7) 8.075 (3193.5)
Spontaneous delivery, number (%) 5 (50) 2 (20) 3 (30) 4 (40)
Breastfeeding, ≤8 weeks, number (%) 10 (100) 10 (100) 10 (100) 10 (100)
Symptoms at the CMA onset    
 Gastrointestinal, n (%) 4 (40) 5 (50) 3 (30)
 Cutaneous, n (%) 8 (80) 8 (80) 7 (70)
 Respiratory, n (%) 1 (10) 3 (30) 3 (30)
Total serum IgE, kU/l (SD) 260.6 (230.9) 255.9 (236.1) 130.4 (167.9) 0.2 (0.1)
Alpha-lactalbumin, kUA/l(SD) 6 (11.2) 0.6 (0.7) 3.1 (3.9)
Beta-lactoglobulin, kUA/l(SD) 4.5 (7.1) 2.2 (3.4) 1.9 (2.6)
Bovine serum albumin, kUA/l(SD) 5.4 (8.7) 0.9 (1.8) 1.9 (3)
nBCasein, kUA/l(SD) 22.7 (39.2) 0.5 (0.4) 1.3 (2.7)
Lactoferrin, kUA/l(SD) 2 (6.1) 0 0